drugset / Trial / NCT03803111

Effects of Iron Therapy and Exercise Training in Patients With Heart Failure and Iron Deficiency

NCT03803111 ↗

Withdrawn Herzzentrum Bremen
RandomizedCrossoverOpen-labelTreatment

Summary

It is the aim of the study to prove, if intravenous supplementation with ferric carboxymaltose in iron-deficient patients with heart failure with reduced ejection fraction (HFrEF) leads to better exercise training effects compared to exercise training without previous iron supplementation.

Timeline

Start
2021-01-01
Primary completion
2022-03-15
Completion
2022-03-15

Outcome

Outcome not reported

Stopped: “Sponsoring and Screening of first patients was not sufficient”

Drugs

EvaluationDrugModalityDoseRoute
Subject Initial FCM Unknown — Intravenous